Position in DHR
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,136,594
+$54,926 QoQ
Shares Held
5,967
+4.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.24%
of 13F equity value
Holder Rank
#1,055
of 2,098 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 36%
Shared 64%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Argyle Capital Partners, LLC holds $1,497,572 across 2 Diagnostics & Research names. DHR ranks #1 (75.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
This page
|
5,967 | $1,136,594 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
720 | $360,978 |
All Filings in DHR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,136,594 | 5,967 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,081,668 | 5,705 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,248,300 | 5,453 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,172,113 | 5,912 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,105,828 | 5,598 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $840,090 | 4,098 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $940,695 | 4,098 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||